1 |
He Y, Døssing KBV, Sloth AB, He X, Rossing M, Kjaer A. Quantitative Evaluation of Stem-like Markers of Human Glioblastoma Using Single-Cell RNA Sequencing Datasets. Cancers (Basel) 2023;15. [PMID: 36900348 DOI: 10.3390/cancers15051557] [Reference Citation Analysis]
|
2 |
Gao Y, Wang Z, Cui Y, Xu M, Weng L. Emerging Strategies of Engineering and Tracking Dendritic Cells for Cancer Immunotherapy. ACS Appl Bio Mater 2023;6:24-43. [PMID: 36520013 DOI: 10.1021/acsabm.2c00790] [Reference Citation Analysis]
|
3 |
Ren M, Yao B, Han B, Li C. Nuclear Imaging of CAR T Immunotherapy to Solid Tumors: In Terms of Biodistribution, Viability, and Cytotoxic Effect. Adv Biol (Weinh) 2023;:e2200293. [PMID: 36642820 DOI: 10.1002/adbi.202200293] [Reference Citation Analysis]
|
4 |
Heo GS, Diekmann J, Thackeray JT, Liu Y. Nuclear Methods for Immune Cell Imaging: Bridging Molecular Imaging and Individualized Medicine. Circ Cardiovasc Imaging 2023;16:e014067. [PMID: 36649445 DOI: 10.1161/CIRCIMAGING.122.014067] [Reference Citation Analysis]
|
5 |
Arnouk S, De Groof TWM, Van Ginderachter JA. Imaging and therapeutic targeting of the tumor immune microenvironment with biologics. Adv Drug Deliv Rev 2022;184:114239. [PMID: 35351469 DOI: 10.1016/j.addr.2022.114239] [Reference Citation Analysis]
|